<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. ___)*
Cardiac Science, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value US $0.001 per share
--------------------------------------------------------------------------------
(Title of Class of Securities)
141410-209
--------------------------------------------------------------------------------
(CUSIP Number)
Mr. Thomas R. Hurtekant
HFC-Cadent, L.P.
1445 Ross at Field, Dallas, Texas 75202-2785
(214) 978-8907
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
July 1, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which the Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE> 2
CUSIP NO. 141410-209 13G PAGE 2 OF 4 PAGES
------------ --- ---
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
HFC - Cadent, L.P. / IRS No. 75-2807762
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
5 SOLE VOTING POWER
NUMBER OF 1,863,478
SHARES ---------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH -0-
REPORTING ---------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH
1,863,478
---------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,863,478
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES [ ]
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.956% based on 18,715,511 shares of common stock outstanding as of
July 1, 2000.
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
PN
--------------------------------------------------------------------------------
<PAGE> 3
CUSIP NO. 141410-209 13G PAGE 3 OF 4 PAGES
------------ --- ---
Item 1(a). Name of Issuer: Cardiac Science, Inc.
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 16931 Milliken
Avenue, Irvine, California 92606
ITEM 2(a). NAME OF PERSON FILING: HFC-Cadent, L.P.
ITEM 2(b). ADDRESS OR PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
1445 Ross at Field, Dallas, Texas 75202-2785
ITEM 2(c). CITIZENSHIP: Delaware
ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock, par value US $0.001
per share
ITEM 2(e). CUSIP NO.: 141410-209
ITEM 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or
(c), check whether the person filing is a:
a. [ ] Broker or Dealer registered under Section 15 of the Act.
b. [ ] Bank as defined in Section 3(a)(6) of the Act.
c. [ ] Insurance Company as defined in Section 3(a)(19) of the Act.
d. [ ] Investment company registered under Section 8 of the Investment
Company Act of 1940.
e. [ ] An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
f. [ ] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
g. [ ] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
h. [ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
i. [ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940;
j. [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
Not applicable.
ITEM 4. OWNERSHIP Provide the following information regarding the aggregate
number and percentage of the class of securities of the issuer identified in
Item 1.
a. Amount Beneficially Owned: 1,863,478
b. Percent of class: 9.956%
c. Number of shares as to which such person has:
i. Sole power to vote or to direct the vote: 1,863,478
ii. Shared power to vote or to direct the vote: 0
iii. Sole power to dispose or to direct the disposition
of: 1,863,478
iv. Shared power to dispose or to direct the disposition
of: 0
<PAGE> 4
CUSIP NO. 141410-209 13G PAGE 4 OF 4 PAGES
------------ --- ---
ITEM 5. OWNERSHIP OF 5 PERCENT OR LESS OF A CLASS. If this statement is being
filed to report the fact that as of the date hereof the reporting person has
ceased to be the beneficial owner of more than 5 percent of the class of
securities, check the following [ ].
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAN 5 PERCENT ON BEHALF OF ANOTHER PERSON.
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE
SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON.
Not applicable.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
ITEM 10. CERTIFICATIONS.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
HFC-Cadent, L.P.
By: Cadent GP, L.P., its general partner
By: HFC-Cadent GP, Inc., its general
partner
Dated: July 11, 2000
By: /s/ S.P. SMILEY
------------------------------
Name: S.P. Smiley
----------------------------
Title: President
---------------------------
